ESMO (European Society for Medical Oncology) shared a post on LinkedIn:
“The latest studies on gastroenteropancreatic (NETTER-2) and cervical (KEYNOTE-826) cancers will be critically reviewed and discussed by experts in the field. Register with your membership for this new ESMO Virtual Journal Club and submit your questions during the live Q&A session!”
More posts featuring ESMO.